Open-Label Placebo Treatment for Acute Postoperative Pain (OLP-POP Study): Study Protocol of a Randomized Controlled Trial

Introduction: Open-label placebos have been proposed as way of using long recognized analgesic placebo effects in an ethical manner. Recent evidence shows efficacy of open-label placebos for clinical conditions, but there is need for more research on open-label placebos in acute pain. In the treatme...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dilan Sezer, Matthijs de Leeuw, Cordula Netzer, Markus Dieterle, Andrea Meyer, Sarah Buergler, Cosima Locher, Wilhelm Ruppen, Jens Gaab, Tobias Schneider
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/f63fce32e34740b9bd3962ad2897def8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f63fce32e34740b9bd3962ad2897def8
record_format dspace
spelling oai:doaj.org-article:f63fce32e34740b9bd3962ad2897def82021-11-05T10:21:51ZOpen-Label Placebo Treatment for Acute Postoperative Pain (OLP-POP Study): Study Protocol of a Randomized Controlled Trial2296-858X10.3389/fmed.2021.687398https://doaj.org/article/f63fce32e34740b9bd3962ad2897def82021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmed.2021.687398/fullhttps://doaj.org/toc/2296-858XIntroduction: Open-label placebos have been proposed as way of using long recognized analgesic placebo effects in an ethical manner. Recent evidence shows efficacy of open-label placebos for clinical conditions, but there is need for more research on open-label placebos in acute pain. In the treatment of acute postoperative pain, minimization of opioid related side effects remains one of the key challenges. Therefore, this study aims at investigating the potential of adding unconditioned open-label placebos to treatment as usual as a means of reducing opioid consumption and its related side effects in patients with acute postoperative pain.Methods and Analysis: This is the protocol of an ongoing single site randomized controlled trial. The first patient was enrolled in May 2020. In total, 70 patients suffering from acute postoperative pain following dorsal lumbar interbody fusion are randomized to either a treatment as usual group or an experimental intervention group. The treatment as usual group consists of participants receiving a patient-controlled morphine pump. On day 1 and 2 post-surgery, patients in the intervention group receive, in addition to treatment as usual, two open-label placebo injections per day along with an evidence-based treatment rationale explaining the mechanisms of placebos. The primary outcome is measured by means of self-administered morphine during day 1 and 2 post-surgery. Several other outcome measures including pain intensity and adverse events as well as potential predictors of placebo response are assessed. Analysis of covariance will be used to answer the primary research question and additional statistical techniques such as generalized linear mixed models will be applied to model the temporal course of morphine consumption.Discussion: This study will provide valuable insights into the efficacy of open-label placebos in acute pain and will potentially constitute an important step toward the implementation of open-label placebos in the clinical management of acute postoperative pain. In addition, it will shed light on a cost-efficient and patient-centered strategy to reduce opioid consumption and its related side effects, without any loss in pain management efficacy.Ethics and Dissemination: The “Ethikkommission Nordwest- und Zentralschweiz” (BASEC2020-00099) approved the study protocol. Results of the analysis will be submitted for publication in a peer-reviewed journal.Clinical Trial Registration: The study is registered at ClinicalTrials.gov (NCT04339023) and is listed in the Swiss national registry at kofam.ch (SNCTP000003720).Dilan SezerMatthijs de LeeuwCordula NetzerMarkus DieterleAndrea MeyerSarah BuerglerCosima LocherCosima LocherWilhelm RuppenJens GaabTobias SchneiderFrontiers Media S.A.articleopen-label placeboacute postoperative painopioidspostoperative analgesiaplacebo analgesialumbar interbody fusionMedicine (General)R5-920ENFrontiers in Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic open-label placebo
acute postoperative pain
opioids
postoperative analgesia
placebo analgesia
lumbar interbody fusion
Medicine (General)
R5-920
spellingShingle open-label placebo
acute postoperative pain
opioids
postoperative analgesia
placebo analgesia
lumbar interbody fusion
Medicine (General)
R5-920
Dilan Sezer
Matthijs de Leeuw
Cordula Netzer
Markus Dieterle
Andrea Meyer
Sarah Buergler
Cosima Locher
Cosima Locher
Wilhelm Ruppen
Jens Gaab
Tobias Schneider
Open-Label Placebo Treatment for Acute Postoperative Pain (OLP-POP Study): Study Protocol of a Randomized Controlled Trial
description Introduction: Open-label placebos have been proposed as way of using long recognized analgesic placebo effects in an ethical manner. Recent evidence shows efficacy of open-label placebos for clinical conditions, but there is need for more research on open-label placebos in acute pain. In the treatment of acute postoperative pain, minimization of opioid related side effects remains one of the key challenges. Therefore, this study aims at investigating the potential of adding unconditioned open-label placebos to treatment as usual as a means of reducing opioid consumption and its related side effects in patients with acute postoperative pain.Methods and Analysis: This is the protocol of an ongoing single site randomized controlled trial. The first patient was enrolled in May 2020. In total, 70 patients suffering from acute postoperative pain following dorsal lumbar interbody fusion are randomized to either a treatment as usual group or an experimental intervention group. The treatment as usual group consists of participants receiving a patient-controlled morphine pump. On day 1 and 2 post-surgery, patients in the intervention group receive, in addition to treatment as usual, two open-label placebo injections per day along with an evidence-based treatment rationale explaining the mechanisms of placebos. The primary outcome is measured by means of self-administered morphine during day 1 and 2 post-surgery. Several other outcome measures including pain intensity and adverse events as well as potential predictors of placebo response are assessed. Analysis of covariance will be used to answer the primary research question and additional statistical techniques such as generalized linear mixed models will be applied to model the temporal course of morphine consumption.Discussion: This study will provide valuable insights into the efficacy of open-label placebos in acute pain and will potentially constitute an important step toward the implementation of open-label placebos in the clinical management of acute postoperative pain. In addition, it will shed light on a cost-efficient and patient-centered strategy to reduce opioid consumption and its related side effects, without any loss in pain management efficacy.Ethics and Dissemination: The “Ethikkommission Nordwest- und Zentralschweiz” (BASEC2020-00099) approved the study protocol. Results of the analysis will be submitted for publication in a peer-reviewed journal.Clinical Trial Registration: The study is registered at ClinicalTrials.gov (NCT04339023) and is listed in the Swiss national registry at kofam.ch (SNCTP000003720).
format article
author Dilan Sezer
Matthijs de Leeuw
Cordula Netzer
Markus Dieterle
Andrea Meyer
Sarah Buergler
Cosima Locher
Cosima Locher
Wilhelm Ruppen
Jens Gaab
Tobias Schneider
author_facet Dilan Sezer
Matthijs de Leeuw
Cordula Netzer
Markus Dieterle
Andrea Meyer
Sarah Buergler
Cosima Locher
Cosima Locher
Wilhelm Ruppen
Jens Gaab
Tobias Schneider
author_sort Dilan Sezer
title Open-Label Placebo Treatment for Acute Postoperative Pain (OLP-POP Study): Study Protocol of a Randomized Controlled Trial
title_short Open-Label Placebo Treatment for Acute Postoperative Pain (OLP-POP Study): Study Protocol of a Randomized Controlled Trial
title_full Open-Label Placebo Treatment for Acute Postoperative Pain (OLP-POP Study): Study Protocol of a Randomized Controlled Trial
title_fullStr Open-Label Placebo Treatment for Acute Postoperative Pain (OLP-POP Study): Study Protocol of a Randomized Controlled Trial
title_full_unstemmed Open-Label Placebo Treatment for Acute Postoperative Pain (OLP-POP Study): Study Protocol of a Randomized Controlled Trial
title_sort open-label placebo treatment for acute postoperative pain (olp-pop study): study protocol of a randomized controlled trial
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/f63fce32e34740b9bd3962ad2897def8
work_keys_str_mv AT dilansezer openlabelplacebotreatmentforacutepostoperativepainolppopstudystudyprotocolofarandomizedcontrolledtrial
AT matthijsdeleeuw openlabelplacebotreatmentforacutepostoperativepainolppopstudystudyprotocolofarandomizedcontrolledtrial
AT cordulanetzer openlabelplacebotreatmentforacutepostoperativepainolppopstudystudyprotocolofarandomizedcontrolledtrial
AT markusdieterle openlabelplacebotreatmentforacutepostoperativepainolppopstudystudyprotocolofarandomizedcontrolledtrial
AT andreameyer openlabelplacebotreatmentforacutepostoperativepainolppopstudystudyprotocolofarandomizedcontrolledtrial
AT sarahbuergler openlabelplacebotreatmentforacutepostoperativepainolppopstudystudyprotocolofarandomizedcontrolledtrial
AT cosimalocher openlabelplacebotreatmentforacutepostoperativepainolppopstudystudyprotocolofarandomizedcontrolledtrial
AT cosimalocher openlabelplacebotreatmentforacutepostoperativepainolppopstudystudyprotocolofarandomizedcontrolledtrial
AT wilhelmruppen openlabelplacebotreatmentforacutepostoperativepainolppopstudystudyprotocolofarandomizedcontrolledtrial
AT jensgaab openlabelplacebotreatmentforacutepostoperativepainolppopstudystudyprotocolofarandomizedcontrolledtrial
AT tobiasschneider openlabelplacebotreatmentforacutepostoperativepainolppopstudystudyprotocolofarandomizedcontrolledtrial
_version_ 1718444324576821248